E. Diamanti-Kandarakis

Reproductive Medicine · 2006–2014

A researcher in the Science corpus: 6 papers; trusts 4 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Reproductive Medicine — 53 citations into it; #183 of 208 by trust here, #16 by citations
• Genetics — 35 citations into it
• Public Health, Environmental and Occupational Health — 30 citations into it
• Cardiology and Cardiovascular Medicine — 20 citations into it

Whom E. Diamanti-Kandarakis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Azziz
2. Bart C. J. M. Fauser
3. D. Barker
4. David B. Goldstein
5. R. Legro
6. F. Grün
7. A. Shelling
8. Joseph W. Thornton

Who trusts E. Diamanti-Kandarakis overall

1. J. Heindel
2. H. Escobar-Morreale
3. D. Dumesic
4. Brandon H Hidaka

Papers from E. Diamanti-Kandarakis's perspective

Ordered by how strongly the researchers E. Diamanti-Kandarakis trusts endorse each paper. Same corpus, a different order for every researcher.

1. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (Journal of Clinical Endocrinology and Metabolism)
2. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
3. Ultrasound assessment of the polycystic ovary: international consensus definitions. (Human Reproduction Update)
4. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (Journal of Clinical Endocrinology and Metabolism)
5. The metabolic syndrome: time for a critical appraisal (Diabetologia)
6. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3‐year follow‐up study (Clinical Endocrinology)
7. Diagnosis and complications of Cushing's syndrome: a consensus statement. (Journal of Clinical Endocrinology and Metabolism)
8. The molecular classification of the clinical manifestations of Crohn's disease. (Gastroenterology)
9. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (Journal of Clinical Endocrinology and Metabolism)
10. Androgen excess in women: experience with over 1000 consecutive patients. (Journal of Clinical Endocrinology and Metabolism)

Their papers

• The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (2014) — 604 citations
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. (2012) — 1,734 citations
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. (2010) — 970 citations
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009) — 2,022 citations
• Endocrine-disrupting chemicals: an Endocrine Society scientific statement. (2009) — 4,219 citations
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006) — 1,909 citations